Radient Pharmaceuticals CorporationTustin, CA United States
Company Description
Radient Pharmaceuticals (formerly AMDL) is ready to hunt down cancer and some day might even be able to do something about it. The company has developed and manufactures an in vitro blood test to detect over a dozen forms of cancer. Marketed as Onko-Sure, the test kits are approved for use in Europe and Asia; in the US the kits are approved for monitoring colorectal cancer, while in Canada it is used to detect lung cancer. Drug manufacturing facilities in China previously accounted for the bulk of the company's income, but it has chosen to focus its efforts on its Onko-Sure products. Other products in its pipeline include a technology with the potential to develop cancer vaccines.
| 2492 Walnut Ave., Ste. 100 | Phone: 714-505-4460 | http://www.amdl.com |
| Tustin, CA 92780 | Fax: 714-505-4464 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Radient Pharmaceuticals Corporation Rankings
Executives
| 15 executives listed for Radient Pharmaceuticals Corporation's Tustin, CA location. | ||
| Chairman and CEO | Douglas MacLellan | |
|---|---|---|
| COO, CFO, and Secretary | Akio Ariura | |
| Director | William Thompson | |
Financials
| Company Type | Public - NYSE Amex: RPC Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 10 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Radient Pharmaceuticals Corporation now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
